NCT02597036 2025-10-23A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid TumorsEli Lilly and CompanyPhase 1 Terminated62 enrolled 25 charts
NCT01634555 2019-02-26A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRIEli Lilly and CompanyPhase 2 Completed29 enrolled 12 charts